![Ashley Hall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ashley Hall
Corporate Officer/Principal bei
STRUCTURE THERAPEUTICS INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Ashley F.
Hall is currently Chief Development Officer at Structure Therapeutics, Inc. since 2024.
Former positions include Chief Development Officer at Reneo Pharmaceuticals, Inc. from 2021 to 2024, Chief Development Officer at Esperion Therapeutics, Inc. from 2019 to 2021, Vice President-Regulatory Affairs at Amgen Rockville, Inc. from 2010 to 2012, Director-World Wide Regulatory Affairs at MedImmune LLC from 2007 to 2009, Vice President-Regulatory Affairs at CancerVax Corp., Vice President-Regulatory & Clinical Affairs at Revogenex Ltd., and Vice President-Regulatory Affairs at Micromet, Inc. Education includes undergraduate studies at the University of California San Diego and graduate studies at the University of San Diego School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.03.2026 | 155’187 ( 0.11% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Ashley Hall
| Unternehmen | Position | Beginn |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | 18.09.2024 |
Ehemalige bekannte Positionen von Ashley Hall
| Unternehmen | Position | Ende |
|---|---|---|
| ONKURE THERAPEUTICS, INC. | Corporate Officer/Principal | 13.09.2024 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | General Counsel | 01.05.2012 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | General Counsel | 01.08.2009 |
Micromet Inc.
 Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | General Counsel | - |
CancerVax Corp.
 CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | General Counsel | - |
Ausbildung von Ashley Hall
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
53
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Commercial Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Revogenex Ltd.
 Revogenex Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of San Diego School of Law
 University of San Diego School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reneo Pharmaceuticals, Inc.
 Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Micromet Inc.
Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | Health Technology |
